NIH Locks Doors for Secret Genome Grant Discussions
Published Date: 4/1/2025
Notice
Summary
The National Human Genome Research Institute is holding a private virtual meeting on May 9, 2025, to review grant applications related to inherited disease research. This meeting is closed to protect sensitive information like trade secrets and personal details. Researchers applying for grants should note this important step in the funding process, which helps decide who gets money for their projects.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed grant review meeting for researchers
If you are a researcher applying for inherited disease research grants, the Center for Inherited Disease Research Access Committee will hold a closed virtual meeting on May 9, 2025 from 11:30 a.m. to 12:30 p.m. to review and evaluate grant applications. The meeting is closed to protect confidential trade secrets, patentable material, and personal information, and it is a formal step that helps decide who receives grant funding.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-22871, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for eye disease, neuronal injury, infectious diseases, and related projects. No public access is allowed to protect private info and trade secrets, but these reviews help decide who gets research money.
2026-22550, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding two closed virtual meetings on November 30, 2026, to review important grant applications. These meetings affect researchers applying for funding in cardiovascular sciences and tobacco regulatory science. No public access is allowed to protect private info and trade secrets, and the reviews help decide who gets research money.
2026-22558, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in early December 2026 to review and evaluate grant applications. These meetings affect researchers and small businesses seeking funding for health-related projects, ensuring privacy for sensitive information. No direct money changes are announced, but these reviews help decide who gets research grants.
2026-22339, Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human
The National Institutes of Health plans to give AntaraCore Systems, Inc. an exclusive license to use new catheter technology that treats dangerous heart rhythm problems called ventricular arrhythmia. This means AntaraCore will have special rights to develop and sell this life-saving treatment. If you want to comment or apply for a license, you must do so by December 2, 2026.
2026-22196, National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting
The National Institute of Diabetes and Digestive and Kidney Diseases is holding a public meeting on May 12, 2027, to discuss important council business and review grant applications. People interested can attend in person or online, but space is limited and some parts of the meeting will be private to protect sensitive information. This meeting affects researchers and organizations seeking funding and sets the stage for future diabetes and kidney disease research support.
2026-22111, Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting
The Eunice Kennedy Shriver National Institute of Child Health & Human Development is holding a virtual meeting on June 4, 2027, to share updates and review grant applications and staff performance. The first half is open to the public, while the second half is private to protect personal privacy. This meeting affects researchers and staff involved with NICHD grants and projects, with no direct cost changes announced.
Previous / Next Documents
Previous: 2025-05513, Glycine From the People's Republic of China: Notice of Preliminary Results of Antidumping Duty Changed Circumstances Review
The U.S. Department of Commerce says Salvi Chemical Industries Limited can now join a special certification process for glycine imports from China. This change affects companies importing glycine and helps make sure the right duties are paid. Starting April 1, 2025, this could impact how much money is collected on these imports and who has to follow the new rules.
Next: 2025-05516, Certain Chocolate Milk Powder and Packaging Thereof; Notice of Institution of Formal Enforcement Proceeding
The U.S. International Trade Commission is cracking down on certain chocolate milk powder and its packaging that violate trademark rules. This affects importers and sellers like Bharat Bazar and Organic Food in California, who must now follow strict orders to stop selling these products. The enforcement started after investigations from 2020 and 2024, signaling serious money and legal consequences for those involved.